structuring-rights-offerings

name	structuring-rights-offerings
description	Designs rights issue structures with subscription ratios, pricing discounts, and standby underwriting arrangements. Use when structuring rights offerings, analyzing dilution protection, or evaluating capital raise alternatives.
tags	["equity-capital-markets"]
metadata	{"author":"casemark","practice_areas":["ECM","IPO Advisory","Equity Origination"],"document_types":["Report"],"skill_modes":["Analysis"]}

Structuring Rights Offerings

Designs rights issue structures with subscription ratios, pricing discounts, and standby underwriting arrangements.

When To Use

• Issuer needs to raise equity capital while giving existing shareholders pre-emptive participation
• Board is evaluating a rights offering versus a marketed follow-on, private placement, or PIPE
• Analyzing dilution impact on shareholders who do not exercise subscription rights
• Structuring standby underwriting or backstop commitments to ensure full subscription
• Pricing a rights offering discount relative to theoretical ex-rights price (TERP)
• Evaluating oversubscription privilege mechanics and allocation methodology

Inputs To Gather

• Issuer profile: current share price, shares outstanding, market capitalization, float, and major shareholder register
• Capital requirement: target gross proceeds, intended use of funds, and minimum acceptable raise
• Market context: recent trading volume, volatility, sector comps, and prevailing market sentiment
• Shareholder base: institutional vs. retail mix, geographic distribution, and any known holders likely to lapse [VERIFY jurisdiction-specific foreign holder exclusion requirements]
• Regulatory framework: listing rules governing maximum discount, record date requirements, subscription period length, and prospectus obligations [VERIFY exchange-specific rules — NYSE, LSE, ASX, HKEX each differ materially]
• Existing constraints: anti-dilution provisions in convertible instruments, shareholder approval thresholds, and any pre-existing standby or underwriting commitments

Workflow

1. Determine subscription ratio and offer price

   • Calculate shares needed: target proceeds / offer price per new share
   • Set subscription ratio (e.g., 1-for-4 means 1 new share for every 4 held)
   • Price the discount to TERP — typical range is 15–35% depending on deal size and market conditions
   • Compute TERP: ((existing shares x current price) + (new shares x offer price)) / total post-offer shares
   • Sensitivity-test the ratio and discount across a range of market price movements (±10%, ±20%)

2. Model dilution and value transfer

   • Calculate theoretical value per right: (current price − offer price) / (ratio denominator + 1)
   • Show dilution impact for non-exercising shareholders (% ownership reduction and economic dilution)
   • Model outcomes at full take-up, partial take-up (e.g., 70%, 85%), and minimum take-up scenarios
   • Assess impact on EPS, NAV per share, and leverage ratios post-raise

3. Design subscription mechanics

   • Define record date, ex-rights date, subscription period (typically 10–21 trading days) [VERIFY local listing rules for minimum period]
   • Determine whether rights are renounceable (tradeable) or non-renounceable
   • If renounceable: specify rights trading period and settlement mechanics
   • Structure oversubscription privilege — capped or uncapped, pro-rata among over-subscribers
   • Address fractional entitlements: aggregate and sell, round down, or round up

4. Structure underwriting / backstop

   • Evaluate standby underwriting (underwriter takes unsubscribed shares) vs. hard underwriting (full commitment)
   • Negotiate sub-underwriting syndicate if deal size warrants it
   • Set underwriting fee (typically 1.5–3.0% of gross proceeds) and standby fee on uncommitted portion
   • Include termination events (MAC clauses, market-out conditions, force majeure)
   • If backstop by major shareholder: address related-party considerations and creep provisions [VERIFY takeover code thresholds — e.g., 30% mandatory bid trigger under UK Takeover Code]

5. Assess regulatory and documentation requirements

   • Determine prospectus vs. cleansing notice vs. exemption pathway [VERIFY — Reg D, Section 708, EU Prospectus Regulation thresholds]
   • Confirm any shareholder approval requirement based on discount or dilution size
   • Prepare timeline: announcement → record date → despatch → subscription close → allotment → trading
   • Identify restricted jurisdictions for foreign shareholders and structure sell-down or nominee arrangements

Output

Deliver a structured rights offering analysis containing:

• Term sheet summary: subscription ratio, offer price, discount to TERP, gross/net proceeds, key dates
• Dilution table: pre- and post-offer shareholding at full, partial, and minimum take-up
• Financial impact analysis: pro forma EPS, NAV/share, net debt/EBITDA, and interest coverage post-raise
• Rights valuation: theoretical value per right, breakeven share price for exercise decision
• Underwriting structure: fee schedule, commitment levels, sub-underwriting allocation, and termination triggers
• Scenario matrix: outcomes across different take-up rates and share price movements
• Comparative analysis: rights offering vs. alternative structures (accelerated bookbuild, placement, PIPE) on cost, dilution, timeline, and certainty of proceeds
• Timeline and process chart: critical path from board approval through allotment

Quality Checks

• TERP calculation cross-checks: verify arithmetic by working backward from TERP to implied proceeds
• Subscription ratio produces whole-number entitlements for round lots (or fractional handling is specified)
• Discount falls within exchange-permitted maximum [VERIFY — e.g., ASX generally caps at ~25% VWAP discount]
• Dilution percentages are internally consistent across full, partial, and zero exercise scenarios
• Underwriting fees benchmark against recent comparable rights offerings in the same market
• Pro forma financial metrics tie to issuer's latest reported financials plus the modeled raise
• Timeline respects minimum regulatory notice periods and trading day requirements
• All jurisdiction-dependent assumptions are flagged with [VERIFY] for counsel review